JN: "101560960" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Exploring the role of galectin-9 and artemin as biomarkers in long COVID with chronic fatigue syndrome: links to inflammation and cognitive function.
Autorzy:: Elahi S; School of Dentistry, Division of Foundational Sciences, Edmonton, AB, Canada.; Li Ka Shing Institute of Virology, Edmonton, AB, Canada.; Women and Children Health Research Institute, Edmonton, AB, Canada.; Cancer Research Institute of Northern Alberta, Edmonton, AB, Canada.; Glycomics Institute of Alberta, Edmonton, AB, Canada.; Alberta Transplant Institute, Edmonton, AB, Canada.
Rezaeifar M; School of Dentistry, Division of Foundational Sciences, Edmonton, AB, Canada.
Osman M; Li Ka Shing Institute of Virology, Edmonton, AB, Canada.; Women and Children Health Research Institute, Edmonton, AB, Canada.; Department of Medicine, Division of Rheumatology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
Shahbaz S; School of Dentistry, Division of Foundational Sciences, Edmonton, AB, Canada.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1443363. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Galectins*/blood
Biomarkers*/blood
Fatigue Syndrome, Chronic*/blood
Fatigue Syndrome, Chronic*/diagnosis
Fatigue Syndrome, Chronic*/etiology
COVID-19*/blood
COVID-19*/complications
COVID-19*/immunology
COVID-19*/diagnosis
Nerve Tissue Proteins*/blood
SARS-CoV-2*
Inflammation*/blood
Humans ; Male ; Female ; Middle Aged ; Adult ; Cognition ; Antigens, Neoplasm ; Biomarkers, Tumor

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 2.

Tytuł:: Case report: sub-clinical extramedullary B-ALL in the setting of relapse following targeted therapy.
Autorzy:: Johns C; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.
Erickson C; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.
Jacobs A; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.
Moon J; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.
Baggott C; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.
Dagher R; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.
Nadel H; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.
Balagtas J; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.
Aftandilian C; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.
Ramakrishna S; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.
Lacayo N; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.
Davis KL; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.
Stieglitz E; Division of Pediatric Oncology, Department of Pediatrics, University of California San Francisco School of Medicine, San Francisco State, San Francisco, CA, United States.
Schultz L; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1423487. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Humans ; Male ; Female ; Neoplasm, Residual ; Immunotherapy, Adoptive/adverse effects ; Adult ; Middle Aged ; Recurrence ; Molecular Targeted Therapy ; Antibodies, Bispecific/therapeutic use ; Neoplasm Recurrence, Local

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 3.

Tytuł:: Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma.
Autorzy:: Aleksandrova K; Institute of Cellular Therapeutics (ICT), Hannover Medical School (MHH), Hanover, Germany.
Leise J; Institute of Cellular Therapeutics (ICT), Hannover Medical School (MHH), Hanover, Germany.
Priesner C; Institute of Cellular Therapeutics (ICT), Hannover Medical School (MHH), Hanover, Germany.
Aktas M; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Apel M; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Assenmacher M; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Bürger I; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Richter A; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Altefrohne P; Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany.
Schubert C; Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany.
Holzinger A; Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT) and University of Regensburg, Regensburg, Germany.
Barden M; Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT) and University of Regensburg, Regensburg, Germany.
Bezler V; Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT) and University of Regensburg, Regensburg, Germany.
von Bergwelt-Baildon M; Medical Department III, Hospital of the Ludwig Maximillian University of Munich (LMU), Munich, Germany.
Borchmann P; Internal Medicine, University Hospital Cologne, Cologne, Germany.
Goudeva L; Institute of Transfusion Medicine and Transplant Engineering (ITMTE), Hannover Medical School, Hannover, Germany.
Glienke W; Institute of Cellular Therapeutics (ICT), Hannover Medical School (MHH), Hanover, Germany.
Arseniev L; Institute of Cellular Therapeutics (ICT), Hannover Medical School (MHH), Hanover, Germany.
Esser R; Institute of Cellular Therapeutics (ICT), Hannover Medical School (MHH), Hanover, Germany.
Abken H; Division of Genetic Immunotherapy, Leibniz Institute for Immunotherapy (LIT) and University of Regensburg, Regensburg, Germany.
Koehl U; Institute of Cellular Therapeutics (ICT), Hannover Medical School (MHH), Hanover, Germany.; Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany.; Institute of Clinical Immunology, University of Leipzig, Leipzig, Germany.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1328368. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article; Clinical Trial, Phase I
MeSH Terms:: Melanoma*/therapy
Melanoma*/immunology
Immunotherapy, Adoptive*/methods
Receptors, Chimeric Antigen*/immunology
Receptors, Chimeric Antigen*/genetics
Receptors, Chimeric Antigen*/metabolism
Antigens, CD20*/immunology
Humans ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; Neoplasm Staging ; Male

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 4.

Tytuł:: Galectin-9 - ligand axis: an emerging therapeutic target for multiple myeloma.
Autorzy:: Shil RK; Department of Cellular and Molecular Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.
Mohammed NBB; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY, United States.; Department of Medical Biochemistry, Faculty of Medicine, South Valley University, Qena, Egypt.
Dimitroff CJ; Department of Cellular and Molecular Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1469794. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article; Review
MeSH Terms:: Multiple Myeloma*/immunology
Multiple Myeloma*/metabolism
Multiple Myeloma*/drug therapy
Multiple Myeloma*/therapy
Galectins*/metabolism
Galectins*/immunology
Tumor Microenvironment*/immunology
Humans ; Ligands ; Animals ; Molecular Targeted Therapy ; Signal Transduction

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 5.

Tytuł:: Causal relationship between 150 skin microbiomes and prostate cancer: insights from bidirectional mendelian randomization and meta-analysis.
Autorzy:: Chen D; Department of Surgery, First People's Hospital of Kunming City & Calmette Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Graduate School, Kunming Medical University, Kunming, China.
Hu S; Department of Surgery, First People's Hospital of Kunming City & Calmette Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Graduate School, Kunming Medical University, Kunming, China.
Wang X; Department of Surgery, First People's Hospital of Kunming City & Calmette Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Graduate School, Kunming Medical University, Kunming, China.
Chen Z; Department of Surgery, First People's Hospital of Kunming City & Calmette Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Graduate School, Kunming Medical University, Kunming, China.
Xu W; Department of Surgery, First People's Hospital of Kunming City & Calmette Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.; Graduate School, Kunming Medical University, Kunming, China.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1463309. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article; Meta-Analysis
MeSH Terms:: Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/microbiology
Mendelian Randomization Analysis*
Microbiota*
Skin*/microbiology
Skin*/pathology
Humans ; Male ; Risk Factors

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 6.

Tytuł:: GSTT1/GSTM1 deficiency aggravated cisplatin-induced acute kidney injury via ROS-triggered ferroptosis.
Autorzy:: Li P; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Research Institute of Nephrology, Zhengzhou University, Zhengzhou, China.; Henan Province Research Center For Kidney Disease, Zhengzhou, China.; Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Zhengzhou, China.
Li D; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Research Institute of Nephrology, Zhengzhou University, Zhengzhou, China.; Henan Province Research Center For Kidney Disease, Zhengzhou, China.; Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Zhengzhou, China.
Lu Y; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Research Institute of Nephrology, Zhengzhou University, Zhengzhou, China.; Henan Province Research Center For Kidney Disease, Zhengzhou, China.; Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Zhengzhou, China.
Pan S; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Research Institute of Nephrology, Zhengzhou University, Zhengzhou, China.; Henan Province Research Center For Kidney Disease, Zhengzhou, China.; Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Zhengzhou, China.
Cheng F; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Research Institute of Nephrology, Zhengzhou University, Zhengzhou, China.; Henan Province Research Center For Kidney Disease, Zhengzhou, China.; Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Zhengzhou, China.
Li S; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Zhang X; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Research Institute of Nephrology, Zhengzhou University, Zhengzhou, China.; Henan Province Research Center For Kidney Disease, Zhengzhou, China.; Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Zhengzhou, China.
Huo J; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Research Institute of Nephrology, Zhengzhou University, Zhengzhou, China.; Henan Province Research Center For Kidney Disease, Zhengzhou, China.; Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Zhengzhou, China.
Liu D; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Research Institute of Nephrology, Zhengzhou University, Zhengzhou, China.; Henan Province Research Center For Kidney Disease, Zhengzhou, China.; Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Zhengzhou, China.
Liu Z; Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Research Institute of Nephrology, Zhengzhou University, Zhengzhou, China.; Henan Province Research Center For Kidney Disease, Zhengzhou, China.; Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Zhengzhou, China.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1457230. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/adverse effects
Acute Kidney Injury*/chemically induced
Acute Kidney Injury*/metabolism
Acute Kidney Injury*/genetics
Glutathione Transferase*/genetics
Glutathione Transferase*/metabolism
Mice, Knockout*
Ferroptosis*/genetics
Reactive Oxygen Species*/metabolism
Animals ; Mice ; Humans ; Male ; Mice, Inbred C57BL ; Antineoplastic Agents/adverse effects ; Oxidative Stress/drug effects ; Disease Models, Animal ; Female

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 7.

Tytuł:: Impact of platelet transfusion refractoriness in the first 30 days post-hematopoietic stem cell transplantation on outcomes of patients with myelodysplastic syndrome.
Autorzy:: Zhang Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
Wang Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
Ma R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Liu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Sun J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Chen X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Yang D; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Pang A; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Zhang R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Ma Q; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Zhai W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
He Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Wei J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Zhang T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Jiang E; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Han M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Feng S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1437176. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Myelodysplastic Syndromes*/therapy
Myelodysplastic Syndromes*/mortality
Platelet Transfusion*
Hematopoietic Stem Cell Transplantation*/methods
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Male ; Female ; Middle Aged ; Adult ; Retrospective Studies ; Aged ; Treatment Outcome ; Young Adult ; Adolescent ; Time Factors

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 8.

Tytuł:: Updates on the controversial roles of regulatory lymphoid cells in idiopathic pulmonary fibrosis.
Autorzy:: Curioni AV; Université Paris Cité, Institut national de la santé et de la recherche médicale (INSERM), Physiopathologie et épidémiologie des maladies respiratoires (PHERE), Paris, France.
Borie R; Université Paris Cité, Institut national de la santé et de la recherche médicale (INSERM), Physiopathologie et épidémiologie des maladies respiratoires (PHERE), Paris, France.; Service Pneumologie A, Assistance publique - Hôpitaux de Paris (AP-HP), Hôpital Bichat, Paris, France.
Crestani B; Université Paris Cité, Institut national de la santé et de la recherche médicale (INSERM), Physiopathologie et épidémiologie des maladies respiratoires (PHERE), Paris, France.; Service Pneumologie A, Assistance publique - Hôpitaux de Paris (AP-HP), Hôpital Bichat, Paris, France.
Helou DG; Université Paris Cité, Institut national de la santé et de la recherche médicale (INSERM), Physiopathologie et épidémiologie des maladies respiratoires (PHERE), Paris, France.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1466901. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article; Review
MeSH Terms:: Idiopathic Pulmonary Fibrosis*/immunology
Idiopathic Pulmonary Fibrosis*/pathology
Idiopathic Pulmonary Fibrosis*/metabolism
T-Lymphocytes, Regulatory*/immunology
B-Lymphocytes, Regulatory*/immunology
B-Lymphocytes, Regulatory*/metabolism
Humans ; Animals ; Transforming Growth Factor beta/metabolism ; Lung/immunology ; Lung/pathology ; Mice ; Disease Models, Animal

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 9.

Tytuł:: Retraction: CCDC88A post-transcriptionally regulates VEGF via miR-101 and subsequently regulates hepatocellular carcinoma.
Corporate Authors:: Frontiers Editorial Office
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1495479. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Retraction of Publication

na półce

Szczegóły

Skocz do pozycji: 10.

Tytuł:: Editorial: Immune metabolism in auto- and allo-immunity.
Autorzy:: Basur L; School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Zhou H; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, United States.
Cheng J; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, United States.
Zang Y; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, United States.
Song G; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, United States.; Department of Cardiology, West Haven VA Medical Center, West Haven, CT, United States.; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
He L; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, United States.
Lan Y; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, United States.; Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Ma Z; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, United States.
Haziot A; Institut National de la Santé et de la Recherche Médicale (INSERM) U976, Paris, France.; Université de Paris, Institut de Recherche Saint Louis, Paris, France.
Jane-Wit D; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, United States.; Department of Cardiology, West Haven VA Medical Center, West Haven, CT, United States.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1483411. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Editorial; Introductory Journal Article
MeSH Terms:: Autoimmunity*
Humans ; Animals

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 11.

Tytuł:: Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV.
Autorzy:: Zou S; Department of Infectious Diseases, Zhongyang Hospital of Wuhan University, Wuhan, China.; Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China.
Guo W; Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China.; Department of Pathology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.
Wu S; Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China.; Department of Nosocomial Infection Management, Zhongnan Hospital of Wuhan University, Wuhan, China.
Ming F; Wuchang District Center for Disease Control and Prevention, Wuhan, China.
Tan Y; Department of Infectious Diseases, Zhongyang Hospital of Wuhan University, Wuhan, China.; Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China.
Wu M; Department of Infectious Diseases, Zhongyang Hospital of Wuhan University, Wuhan, China.; Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China.
Tang W; Guangdong Second Provincial General Hospital, Guangdong, China.; The University of North Carolina at Chapel Hill Project-China, Guangzhou, China.
Liang K; Department of Infectious Diseases, Zhongyang Hospital of Wuhan University, Wuhan, China.; Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China.; Department of Nosocomial Infection Management, Zhongnan Hospital of Wuhan University, Wuhan, China.; Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, China.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1494940. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Published Erratum

na półce

Szczegóły

Skocz do pozycji: 12.

Tytuł:: Selected stem cell populations in pediatric acute lymphoblastic leukemia.
Autorzy:: Krętowska-Grunwald A; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland.; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, Bialystok, Poland.
Sawicka-Żukowska M; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, Bialystok, Poland.
Starosz A; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland.
Krawczuk-Rybak M; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, Bialystok, Poland.
Moniuszko M; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland.; Clinical Department of Allergic and Internal Diseases, Medical University of Bialystok, Bialystok, Poland.
Grubczak K; Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1446687. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Precursor Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Hematopoietic Stem Cells*/pathology
Humans ; Child ; Male ; Female ; Child, Preschool ; Retrospective Studies ; Adolescent ; Infant ; Flow Cytometry ; Neoplasm, Residual

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 13.

Tytuł:: Differential expression of HIV target cells CCR5 and α4β7 in tissue resident memory CD4 T cells in endocervix during the menstrual cycle of HIV seronegative women.
Autorzy:: Govindaraj S; Department of Pathology and Laboratory Medicine, Emory Vaccine Center, Emory National Primate Research Center (ENPRC), Emory University, Atlanta, GA, United States.; Division of Microbiology and Immunology, Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.
Tyree S; Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, United States.
Herring GB; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.; Grady Ponce de Leon Center, Grady Health System, Atlanta, GA, United States.
Rahman SJ; Department of Pathology and Laboratory Medicine, Emory Vaccine Center, Emory National Primate Research Center (ENPRC), Emory University, Atlanta, GA, United States.; Division of Microbiology and Immunology, Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.
Babu H; Department of Pathology and Laboratory Medicine, Emory Vaccine Center, Emory National Primate Research Center (ENPRC), Emory University, Atlanta, GA, United States.; Division of Microbiology and Immunology, Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.
Ibegbu C; Division of Microbiology and Immunology, Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.
Young MR; Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, United States.
Mehta CC; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.
Haddad LB; Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, United States.; Center for Biomedical Research, Population Council, New York, NY, United States.
Smith AK; Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, United States.
Velu V; Department of Pathology and Laboratory Medicine, Emory Vaccine Center, Emory National Primate Research Center (ENPRC), Emory University, Atlanta, GA, United States.; Division of Microbiology and Immunology, Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1456652. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Receptors, CCR5*/metabolism
CD4-Positive T-Lymphocytes*/immunology
CD4-Positive T-Lymphocytes*/metabolism
Cervix Uteri*/immunology
Cervix Uteri*/metabolism
Immunologic Memory*
Menstrual Cycle*/immunology
Humans ; Female ; Adult ; HIV Infections/immunology ; HIV Infections/virology ; Young Adult ; Cytokines/metabolism ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism ; Integrins

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 14.

Tytuł:: Plasma adenosine deaminase-1 and -2 activities are lower at birth in Papua New Guinea than in The Gambia but converge over the first weeks of life.
Autorzy:: Kouyate TS; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.
Nguyen AN; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.
Plotkin AL; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.
Ford R; Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
Idoko OT; Vaccines & Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, Gambia.; The Vaccine Centre, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Odumade OA; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Division of Medicine Critical Care, Boston Children's Hospital, Boston, MA, United States.
Masiria G; Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
Jude J; Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
Diray-Arce J; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.
McEnaney K; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.
Ozonoff A; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Broad Institute of Massachusetts Institute of Technology & Harvard, Cambridge, MA, United States.
Steen H; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Department of Pathology, Boston Children's Hospital, Boston, MA, United States.
Kollmann TR; Telethon Kids Institute, Subiaco, WA, Australia.
Richmond PC; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.; Division of Pediatrics, School of Medicine, University of Western Australia, Perth Children's Hospital, Perth, WA, Australia.
van den Biggelaar AHJ; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.
Kampmann B; Vaccines & Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, Gambia.; Charité Centre for Global Health and Institute for International Health, Charité - Universitätsmedizin, Berlin, Germany.
Pomat W; Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
Levy O; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Broad Institute of Massachusetts Institute of Technology & Harvard, Cambridge, MA, United States.
Smolen KK; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1425349. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Adenosine Deaminase*/blood
Humans ; Gambia ; Papua New Guinea ; Infant, Newborn ; Female ; Male ; Infant ; Intercellular Signaling Peptides and Proteins

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 15.

Tytuł:: The role of cGAS-STING signaling in rheumatoid arthritis: from pathogenesis to therapeutic targets.
Autorzy:: Zhu Q; Department of Laboratory Medicine, Shangyu People's Hospital of Shaoxing, Shaoxing University, Shaoxing, China.
Zhou H; Department of Laboratory Medicine, Wuxi Ninth People's Hospital Affiliated to Soochow University, Wuxi, China.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1466023. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article; Review
MeSH Terms:: Nucleotidyltransferases*/metabolism
Membrane Proteins*/metabolism
Arthritis, Rheumatoid*/immunology
Arthritis, Rheumatoid*/metabolism
Arthritis, Rheumatoid*/etiology
Arthritis, Rheumatoid*/drug therapy
Signal Transduction*
Humans ; Animals ; Molecular Targeted Therapy ; Immunity, Innate

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 16.

Tytuł:: Transformation of macrophages into myofibroblasts in fibrosis-related diseases: emerging biological concepts and potential mechanism.
Autorzy:: Li X; Health Science Center, Chifeng University, Chifeng, China.
Liu Y; Rehabilitation Medicine College, Shandong Second Medical University, Jinan, China.
Tang Y; Department of Emergency, Affiliated Hospital of Chifeng University, Chifeng, China.
Xia Z; Department of Library, Children's Hospital Affiliated to Shandong University, Jinan, China.; Department of Library, Jinan Children's Hospital, Jinan, China.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1474688. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article; Review
MeSH Terms:: Myofibroblasts*/metabolism
Myofibroblasts*/pathology
Myofibroblasts*/immunology
Macrophages*/immunology
Macrophages*/metabolism
Fibrosis*
Signal Transduction*
Humans ; Animals ; Transforming Growth Factor beta/metabolism ; Pulmonary Fibrosis/pathology ; Pulmonary Fibrosis/metabolism ; Pulmonary Fibrosis/etiology ; Pulmonary Fibrosis/immunology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 17.

Tytuł:: Metabolite, immunocyte phenotype, and lymphoma: a Mendelian randomization study.
Autorzy:: Fan C; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Yuan P; Hospital of University of International Business and Economics, Beijing, China.
Yang X; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Zhang W; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Wang X; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Xie J; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
He J; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Chen H; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Yan L; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Shi Z; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1431261. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Mendelian Randomization Analysis*
Lymphoma*/immunology
Lymphoma*/genetics
Phenotype*
Genome-Wide Association Study*
Humans ; Polymorphism, Single Nucleotide ; Genetic Predisposition to Disease ; Metabolome

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 18.

Tytuł:: Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects.
Autorzy:: Slavny P; Discovery & Engineering Division, Iontas Ltd./FairJourney Biologics, Cambridge, United Kingdom.
Hegde M; Technology Division, Iontas/FairJourney Biologics, Cambridge, United Kingdom.
Doerner A; Antibody Discovery & Protein Engineering, Merck Healthcare KGaA, Darmstadt, Germany.
Parthiban K; Discovery & Engineering Division, Iontas Ltd./FairJourney Biologics, Cambridge, United Kingdom.
McCafferty J; Maxion Therapeutics, Cambridge, United Kingdom.; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Zielonka S; Antibody Discovery & Protein Engineering, Merck Healthcare KGaA, Darmstadt, Germany.
Hoet R; Technology Division, Iontas/FairJourney Biologics, Cambridge, United Kingdom.; Technology Division, FairJourney Biologics, Porto, Portugal.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 24; Vol. 15, pp. 1469329. Date of Electronic Publication: 2024 Sep 24 (Print Publication: 2024).
Typ publikacji:: Journal Article; Review
MeSH Terms:: Genetic Engineering*
Humans ; Animals ; Mammals ; Cell Surface Display Techniques ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal/immunology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 19.

Tytuł:: DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways.
Autorzy:: Liu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Gong D; Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Neurological Institute, Tianjin, China.
Sun H; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Feng F; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Xu J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Sun X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Gong L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Yu Z; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Fang T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Xu Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Lyu R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Wang T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Wang W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Tian W; ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China.
Qiu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.; Gobroad Healthcare Group, Beijing, China.
An G; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Hao M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 24; Vol. 15, pp. 1470328. Date of Electronic Publication: 2024 Sep 24 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Multiple Myeloma*/immunology
Multiple Myeloma*/genetics
Multiple Myeloma*/pathology
N-Myc Proto-Oncogene Protein*/genetics
Proto-Oncogene Proteins c-myc*/genetics
Proto-Oncogene Proteins c-myc*/metabolism
Tumor Protein p73*/genetics
Tumor Protein p73*/immunology
Humans ; Animals ; Cell Line, Tumor ; Mice ; Cell Proliferation ; Signal Transduction ; Gene Expression Regulation, Neoplastic ; Tumor Escape ; Disease Progression ; Drug Resistance, Neoplasm/genetics ; Tumor Microenvironment/immunology ; Tumor Microenvironment/genetics

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 20.

Tytuł:: Editorial: Immunological non-responders in HIV infection.
Autorzy:: Saidakova E; Biology Department, Perm State University, Perm, Russia.; Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences, Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, Perm, Russia.
Shmagel K; Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences, Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, Perm, Russia.
Sieg S; Department of Medicine, Division of Infectious Diseases and HIV Medicine, Case Western Reserve University, Cleveland, OH, United States.
Hunt P; Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, United States.; Pokaż więcej
Źródło:: Frontiers in immunology [Front Immunol] 2024 Sep 24; Vol. 15, pp. 1487565. Date of Electronic Publication: 2024 Sep 24 (Print Publication: 2024).
Typ publikacji:: Editorial; Introductory Journal Article
MeSH Terms:: HIV Infections*/immunology
HIV Infections*/drug therapy
Humans ; Anti-HIV Agents/therapeutic use ; HIV-1/immunology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Informacja

Wyszukujesz frazę ""101560960"" wg kryterium: JN